Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort
Obesity · 2025
DOI: 10.1002/oby.24242 ↗At a glance
Randomisierte kontrollierte Studie in Obesity, 2025. Written by Rebecca Palmer and 9 co-authors. Institution: Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA. Major MEDLINE topics: Glycated Hemoglobin, Adiposity, Insulin, Diabetes Mellitus, Type 2. Cited 9 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIDDK NIH HHS, NIA NIH HHS, National Institute on Aging.
Abstract (original language)
Objective
The objective of this study was to elucidate associations between adiposity reduction and changes in HbA1c and insulin use among adults with type 2 diabetes and overweight or obesity.
Methods
Changes in BMI, waist circumference, and total percent fat mass were obtained over 8 years among 1316 individuals (aged 45–76 years) enrolled in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss. Generalized linear models were used to assess relationships between 5% decreases in adiposity measures with glycated hemoglobin (HbA1c) and insulin use over time.
Results
A 5% reduction in total percent fat was associated with 0.15% (95% CI: 0.12%–0.18%) lower mean HbA1c. Similarly, 5% reductions in waist circumference and BMI were also associated with slightly lower mean HbA1c: 0.16% (95% CI: 0.13%–0.19%) and 0.13% (95% CI: 0.11%–0.16%), respectively. These reductions were associated with lower odds of insulin use over time, ranging from 21% lower odds for a 5% reduction in percent body fat to 32% lower odds for 5% reductions in waist circumference and BMI. Associations were evident across subgroups defined by sex, diabetes duration, obesity status, and intervention assignment.
Conclusions
Reductions in adiposity are associated with stabilized and slightly lower HbA1c and a marked reduction in the need for insulin therapy. These benefits generalize across clinical subgroups.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Health and Exercise Sciences, Wake Forest University, Winston-Salem, North Carolina, USA.
- Division of Metabolism, Endocrinology, and Nutrition, VA Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.
- Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
ORCID profiles: Kristen M Beavers, Denise K Houston, Karen C Johnson, Mark A Espeland
Funding
- NIDDK NIH HHS
- NIA NIH HHS
- National Institute on Aging
- National Institute of Diabetes and Digestive and Kidney Diseases
Cite
APA
Palmer, R., Neiberg, R. H., Beavers, K. M., Kahn, S. E., Houston, D. K., Wagenknecht, L., Johnson, K. C., Pownall, H. J., Espeland, M. A., & Action for Health in Diabetes (Look AHEAD) Aging Study Group (2025). Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort. Obesity. https://doi.org/10.1002/oby.24242
Vancouver
Palmer R, Neiberg RH, Beavers KM, Kahn SE, Houston DK, Wagenknecht L, et al. Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort. Obesity. 2025. doi:10.1002/oby.24242
BibTeX
@article{Palmer2025,
author = {Palmer, Rebecca and Neiberg, Rebecca H and Beavers, Kristen M and Kahn, Steven E and Houston, Denise K and Wagenknecht, Lynne and Johnson, Karen C and Pownall, Henry J and Espeland, Mark A and Action for Health in Diabetes (Look AHEAD) Aging Study Group, Action for Health in Diabetes (Look AHEAD) Aging Study Group},
title = {Associations between decreases in adiposity and reductions in HbA1c and insulin use in the Look AHEAD cohort},
journal = {Obesity},
year = {2025},
doi = {10.1002/oby.24242}
}
EUVIMED